Skip to main content
OpenTrials

Clinical trial condition

Non-Small-Cell Lung Cancer

Explore clinical trials studying Non-Small-Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

87 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Non-Small-Cell Lung Cancer trial results

Completed

Non-small Cell Lung Cancer Registry

NCT00099541

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Birmingham Hematology and Oncology Associates Birmingham, Alabama, United States
  • Hembree Cancer Center-St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • Pacific Cancer Medical Center Inc. Anaheim, California, United States
  • Bay Area Cancer Research Group Concord, California, United States
View all 101 locations
View Trial Details
Active, Not Recruiting

Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer

NCT02609776

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Duarte, California, United States
  • La Jolla, California, United States
  • Orange, California, United States
  • Santa Monica, California, United States
View all 69 locations
View Trial Details
Active, Not Recruiting

Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations

NCT06245837

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Arkhangelsk, Russia
  • Research Site Barnaul, Russia
  • Research Site Irkutsk, Russia
  • Research Site Kemerovo, Russia
View all 16 locations
View Trial Details
Active, Not Recruiting

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

NCT03860272

Conditions
Adnexal Diseases, Advanced Cancer, Angiosarcoma, +42 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • The Angeles Clinic & Research Institute, a Cedars-Sinai Affiliate Los Angeles, California, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Lorlatinib Continuation Study

NCT05144997

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • The First affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Chest Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 27 locations
View Trial Details
Active, Not Recruiting

PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %

NCT04547504

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • CH du Pays d'Aix Aix-en-Provence, France
  • CHU AMIENS - Hôpital Sud Amiens, France
  • Chu Angers Angers, France
  • CHRU de Brest Brest, France
View all 29 locations
View Trial Details

Related conditions